Acquisitions - Expenses (Details) - VectivBio Holding AG and its subsidiaries $ in Millions	12 Months Ended
Dec. 31, 2023 USD ($)
Acquisitions
Asset acquisition, acquisition related costs	$ 55.6
Selling, General and Administrative Expenses
Acquisitions
Asset acquisition, acquisition related costs	25.6
Research and Development Expense
Acquisitions
Asset acquisition, acquisition related costs	15.1
Restructuring Charges
Acquisitions
Asset acquisition, acquisition related costs	$ 14.9

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 15
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480123/805-50-15-3

Name:	us-gaap_AssetAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration